[HTML][HTML] Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis

O Teuffel, MC Ethier, SMH Alibhai, J Beyene, L Sung - Annals of oncology, 2011 - Elsevier
Background In some centers, outpatient management for cancer patients with low-risk febrile
neutropenia (FN) has been implemented into routine clinical practice. Our objective was to …

Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia

LS Elting, C Lu, CP Escalante, SH Giordano… - Journal of clinical …, 2008 - ascopubs.org
Purpose We retrospectively compared the outcomes and costs of outpatient and inpatient
management of low-risk outpatients who presented to an emergency department with febrile …

[引用][C] Risk-stratifying treatment strategies for febrile neutropenia—tools, tools everywhere, and not a single one that works?

DT Wijeratne, K Wright, B Gyawali - JCO Oncology Practice, 2021 - ascopubs.org
Febrile neutropenia (FN) is a common complication among patients with cancer receiving
cancer therapy. 1-3 Studies estimate that 10%-50% of patients with solid tumors and up to …

Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial

JA Talcott, BY Yeap, JA Clark, RD Siegel… - Journal of clinical …, 2011 - ascopubs.org
Purpose Febrile neutropenia commonly complicates cancer chemotherapy. Outpatient
treatment may reduce costs and improve patient comfort but risk progression of undetected …

Outpatient management of febrile neutropenia: time to revise the present treatment strategy.

M Carstensen, JB Sørensen - The journal of supportive oncology, 2008 - europepmc.org
A comment on this article appears in" Outpatient management of febrile neutropenia:
concerns for the future." J Support Oncol. 2008 May-Jun; 6 (5): 217-8. A comment on this …

Outpatient therapy for febrile neutropenia

H Innes, E Marshall - Current Opinion in Oncology, 2007 - journals.lww.com
All patients with febrile neutropenia should undergo risk stratification on admission, and low-
risk patients should be considered eligible for combination oral antibiotics from the outset …

Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America …

RA Taplitz, EB Kennedy, EJ Bow, J Crews… - Journal of Clinical …, 2018 - ascopubs.org
Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA)
guideline on outpatient management of fever and neutropenia in patients with cancer …

Outpatient treatment for people with cancer who develop a low‐risk febrile neutropaenic event

R Rivas‐Ruiz, M Villasis‐Keever… - Cochrane Database …, 2019 - cochranelibrary.com
Background People with febrile neutropaenia are usually treated in a hospital setting.
Recently, treatment with oral antibiotics has been proven to be as effective as intravenous …

Prescribing empiric antibiotics for febrile neutropenia: compliance with institutional febrile neutropenia guidelines

D Naeem, MA Alshamrani, MA Aseeri, MA Khan - Pharmacy, 2018 - mdpi.com
Background: Febrile neutropenia (FN) is an oncologic emergency which should be treated
immediately with empiric antibiotics. Different institutions observe different antibiograms and …

Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes

JD Wright, AI Neugut, CV Ananth, SN Lewin… - JAMA internal …, 2013 - jamanetwork.com
Importance Although febrile neutropenia (FN) is a major source of morbidity and mortality for
patients with solid tumors, little is known about the use of guideline-based care. Objectives …